Literature DB >> 11297963

UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years.

C C Bennett, A Johnson, D J Field, D Elbourne.   

Abstract

Extracorporeal membrane oxygenation (ECMO) is a supportive intensive-care technique used for babies with acute respiratory failure. We examined morbidity at age 4 years in surviving children recruited to the UK Collaborative ECMO Trial, and provide long-term data on ECMO support compared with contemporary conventional care. The neonatal ECMO policy resulted in improved survival and a favourable outcome. We therefore advocate the safety and efficacy of this intervention.

Entities:  

Mesh：

Year:  2001        PMID： 11297963     DOI： 10.1016/S0140-6736(00)04310-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


  28 in total

1.  Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience.

Authors:  K Khambekar; S Nichani; D K Luyt; G Peek; R K Firmin; D J Field; H C Pandya
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-09-13       Impact factor: 5.747

Review 2.  Managing the baby with a patent ductus arteriosus. More questions than answers?

Authors:  P W Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

3.  Looking beyond survival rates: neurological outcomes after extracorporeal life support.

Authors:  Kate L Brown; Graeme MacLaren; Bradley S Marino
Journal:  Intensive Care Med       Date:  2013-08-14       Impact factor: 17.440

4.  The impact of networks on clinical trials in the United Kingdom.

Authors:  Sze May Ng; Alan Michael Weindling
Journal:  Trials       Date:  2009-11-04       Impact factor: 2.279

5.  Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes.

Authors:  Deepthi Alapati; Zubair H Aghai; Md Jobayer Hossain; Daniel R Dirnberger; Mark T Ogino; Thomas H Shaffer
Journal:  Pediatr Crit Care Med       Date:  2017-07       Impact factor: 3.624

6.  A comprehensive study of clinical biomarkers, use of inotropic medications and fluid resuscitation in newborns with persistent pulmonary hypertension.

Authors:  Janardhan Mydam; Marwan Zidan; Nitin Shashikant Chouthai
Journal:  Pediatr Cardiol       Date:  2014-08-09       Impact factor: 1.655

Review 7.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

8.  Predicting outcome in ex-premature infants supported with extracorporeal membrane oxygenation for acute hypoxic respiratory failure.

Authors:  K L Brown; G Walker; D J Grant; K Tanner; D A Ridout; L S Shekerdemian; J H Smith; C Davis; R K Firmin; A P Goldman
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

9.  Neonatal ECMO Study of Temperature (NEST)--a randomised controlled trial.

Authors:  David J Field; Richard Firmin; Denis V Azzopardi; Frances Cowan; Edmund Juszczak; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2010-04-19       Impact factor: 2.125

10.  Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial.

Authors:  S Petrou; L Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-05       Impact factor: 5.747
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.